Aspen Aerogels (NYSE:ASPN) Price Target Increased to $30.00 by Analysts at B. Riley

Aspen Aerogels (NYSE:ASPN) had its price target lifted by B. Riley from $24.00 to $30.00 in a research note published on Friday morning, Benzinga reports. B. Riley currently has a buy rating on the construction company’s stock.

Several other analysts also recently commented on ASPN. Piper Sandler increased their price objective on Aspen Aerogels from $20.00 to $29.00 and gave the stock an overweight rating in a research note on Friday. HC Wainwright raised their price objective on Aspen Aerogels from $20.00 to $25.00 and gave the company a buy rating in a research note on Friday. TheStreet raised shares of Aspen Aerogels from a d+ rating to a c- rating in a report on Wednesday, March 6th. Finally, Roth Mkm reiterated a buy rating and issued a $22.00 target price on shares of Aspen Aerogels in a report on Tuesday. One equities research analyst has rated the stock with a sell rating and six have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Aspen Aerogels currently has a consensus rating of Moderate Buy and a consensus target price of $25.17.

Aspen Aerogels Stock Performance

ASPN traded up $1.26 during midday trading on Friday, hitting $25.11. The company had a trading volume of 3,351,897 shares, compared to its average volume of 1,155,989. The stock’s 50 day moving average price is $16.72 and its 200 day moving average price is $13.69. The company has a current ratio of 3.41, a quick ratio of 2.91 and a debt-to-equity ratio of 0.24. Aspen Aerogels has a 52 week low of $5.32 and a 52 week high of $25.65.

Aspen Aerogels (NYSE:ASPN) last released its quarterly earnings data on Tuesday, February 13th. The construction company reported ($0.01) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.12) by $0.11. The firm had revenue of $84.22 million for the quarter, compared to analyst estimates of $83.82 million. Aspen Aerogels had a negative net margin of 10.73% and a negative return on equity of 6.54%. During the same period last year, the firm earned ($0.20) earnings per share. As a group, analysts predict that Aspen Aerogels will post 0.03 EPS for the current year.

Institutional Trading of Aspen Aerogels

Hedge funds have recently added to or reduced their stakes in the stock. Mirae Asset Global Investments Co. Ltd. increased its stake in shares of Aspen Aerogels by 71.4% during the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 23,052 shares of the construction company’s stock worth $198,000 after purchasing an additional 9,601 shares during the last quarter. Levin Capital Strategies L.P. increased its position in Aspen Aerogels by 48.3% in the third quarter. Levin Capital Strategies L.P. now owns 70,613 shares of the construction company’s stock worth $607,000 after buying an additional 23,000 shares during the last quarter. Principal Financial Group Inc. bought a new stake in shares of Aspen Aerogels in the third quarter valued at $449,000. Rice Hall James & Associates LLC grew its stake in shares of Aspen Aerogels by 385.0% during the 3rd quarter. Rice Hall James & Associates LLC now owns 623,135 shares of the construction company’s stock worth $5,359,000 after acquiring an additional 494,662 shares during the period. Finally, Mesirow Financial Investment Management Inc. purchased a new stake in Aspen Aerogels in the 3rd quarter worth about $334,000. Institutional investors own 97.64% of the company’s stock.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.